Zepbound Patient Assistance: What Exists, and What Does Not

There is no free-drug patient assistance program for Zepbound. We checked the Lilly Cares Foundation's own list of available medications on August 29, 2026: it runs from Basaglar to Verzenio, and neither Zepbound nor Mounjaro appears on it¹. Trulicity, a different Lilly GLP-1, is listed — tirzepatide is not, in either of its brands.

That matters because "patient assistance" is the phrase people search when they cannot afford this drug, and much of what is published in reply is wrong in a specific way: several sites state that Lilly Cares covers Mounjaro for diabetes but not Zepbound for weight loss. As of today's check, it covers neither. If you are uninsured and looking for donated Zepbound, that route does not exist, and knowing it now saves you an application cycle.

What does exist is a set of price reductions, and they are worth real money. This page ranks them by what you would actually pay.

The routes that actually lower the price

1. The Medicare GLP-1 Bridge — $50 a month, if you are on Part D

The largest reduction available to anyone, and the newest. Since July 1, 2026, a CMS demonstration lets eligible Medicare Part D enrollees fill the Zepbound KwikPen for a flat $50 monthly copay, running through December 31, 2027².

The catches are specific: it covers the KwikPen only — not the single-dose vials or single-dose pens — and the $50 does not count toward your Part D deductible or the $2,100 out-of-pocket cap. Eligibility, the BMI criteria and the prior-authorization route are in does Medicare cover tirzepatide.

2. The manufacturer savings card — as little as $25 a month, if your plan covers Zepbound

If you have commercial insurance that covers Zepbound, Lilly's savings card can bring your cost to as little as $25 a month, for up to 13 fills a year³. This is the cheapest route in the whole landscape, and it is the one most often missed by people who assume their copay is fixed.

If you have commercial insurance that does not cover Zepbound, a separate version of the card puts the single-dose pen at $499 a month³ — which is worse than the self-pay vial route below at every dose, so compare before you enroll.

Government insurance is excluded from the card entirely. Medicare, Medicaid, TRICARE and VA patients cannot use it — which is exactly the gap the Bridge above was created to fill.

3. LillyDirect self-pay — $299 to $449 a month, available to anyone with a prescription

Buying direct from Lilly's own pharmacy as single-dose vials costs $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg up, for a 28-day supply. That ladder has been in force since December 1, 2025⁴, and since February 23, 2026 the four-dose KwikPen is offered at the same prices⁵.

The condition attached is the one most pages omit: the higher tiers hold only inside the Self Pay Journey Program, which requires each refill within about 45 days of your last delivery. Miss the window and the dose reverts to $599 at 7.5 mg, $699 at 10 mg, $849 at 12.5 mg or $1,049 at 15 mg⁴. The format trade-off is in vials vs pens, and the full route map in Zepbound cost and savings.

4. Appeal the denial before you give up on coverage

If a commercial plan denied Zepbound, that denial is not always final, and an appeal costs nothing but time. What a plan will usually want to see is documented BMI meeting the label criteria, a related condition, and a record of prior attempts at weight management. We cover what plans ask for in does insurance cover Zepbound.

Routes that will be suggested to you, and what they are actually worth

Discount cards (GoodRx, SingleCare). These work on the retail pharmacy price, not on LillyDirect. We priced both against Lilly's own ladder tier by tier: see GoodRx for Zepbound and SingleCare for Zepbound. The short version is that they match Lilly's ladder rather than beating it.

TrumpRx. A federal directory, not a discount. Its Zepbound listing routes you to LillyDirect at the LillyDirect price — a real saving only if you were paying the roughly $1,087 list price. The arithmetic is in TrumpRx and Zepbound.

Compounded tirzepatide. Telehealth programs sell compounded tirzepatide well below brand pricing, and for many readers this is the route they can actually afford. It is a different product — pharmacy-prepared, not FDA-approved, and not what the pivotal trials tested — sitting on narrower legal ground since the shortage resolved⁶. If you go this way, go in knowing that: is compounded tirzepatide still legal? and the cheapest programs we track, each with the price and the date we verified it.

Anything selling tirzepatide without a prescription. Not a route. "Research peptide" vendors sell material labeled not for human consumption, with no potency or sterility guarantee — see the tirzepatide gray market.

If none of these reach your budget

The honest position, and it is worth saying plainly: for an uninsured patient, the LillyDirect self-pay floor for brand Zepbound is $299 a month at the starting dose, and there is no charitable program that goes below it. That is a real barrier and no amount of route-hunting removes it.

Three things are still worth doing. Ask the prescriber whether a KwikPen prescription changes anything for you — it is the only format the Medicare Bridge covers, and it costs the same self-pay. Check whether your state Medicaid program covers anti-obesity medication, since state policies differ and several have expanded. And if you are close to a coverage decision, appeal it rather than assuming.

The bottom line

Lilly Cares does not list Zepbound or Mounjaro, so the free-drug program people are looking for does not exist for tirzepatide¹. The routes that do work, in order of what you would pay: the Medicare GLP-1 Bridge at $50 if you are on Part D²; the savings card at $25 if commercial insurance covers it³; LillyDirect self-pay at $299–$449 by dose for anyone with a prescription, on a 45-day refill condition⁴; and an appeal if you were denied. Discount cards match Lilly's ladder rather than beating it, and TrumpRx routes to the same price. Compounded tirzepatide is cheaper and is a different product with a different legal footing.